Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT02389959
Brief Title:
Intranasal Bevacizumab for HHT-Related Epistaxis
Official Title:
Intranasal Bevacizumab for HHT-Related Epistaxis
Study:
NCT02389959
Protocol Section:
NCT02389959